Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more common gastrointestinal side effects of Mounjaro (tirzepatide), reported by a meaningful proportion of people during early treatment or after a dose increase. It happens because the medicine slows digestion and alters the way your gut handles food and fluid — changes that your bowel often protests at first. Most people find it settles within days to two weeks. As a prescription-only medicine, Mounjaro is assessed by a clinician before it is issued; suitability, including how to handle side effects like this one, is part of that conversation. If you're reading this at 6am because last night was rough, you're not alone, and there are practical things that actually help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) which together slow the rate at which your stomach empties and signal fullness to the brain. That slower gastric emptying has a knock-on effect further down the digestive tract. Food and liquid move through the small intestine at an unfamiliar pace, and the colon ends up handling more water than usual, which loosens stools. The result, for many people, is diarrhoea, particularly in the first few weeks of treatment or after stepping up to a new dose.
There is a more detailed explanation of the physiological mechanisms behind this on our page covering why Mounjaro makes you have diarrhoea, but the short version is that your gut is not malfunctioning, it is reacting to a genuine shift in how hormones regulate digestion. The NHS patient information for tirzepatide lists diarrhoea explicitly among the common side effects of this medicine. That classification means it has been reported by between 1 in 10 and 1 in 100 people in clinical studies, common enough to be expected, not common enough to be inevitable.
Fatty or very rich foods tend to make it worse, because high-fat meals already slow gastric emptying independently of the medicine. Eating smaller, lower-fat meals can noticeably reduce the frequency and severity of loose stools, especially in the first month.
For most people, the worst of it falls in the first one to three weeks after starting or after a dose step-up. The gut adapts, not because the medicine stops working, but because the receptors involved in gastric motility gradually accommodate a new baseline. By week four of a given dose, many people report that their bowel habits have largely normalised.
If you want to understand the fuller picture of how this fits alongside Mounjaro's other gastrointestinal effects, our guide to Mounjaro diarrhoea as a side effect covers what participants in the SURMOUNT clinical programme experienced across the treatment period. The broader Mounjaro side effects page puts diarrhoea in context alongside nausea, constipation and the other GI symptoms that can occur.
A few practical adjustments make a real difference: eating more slowly, choosing smaller portions, avoiding alcohol, and giving the gut a longer gap between meals. Keeping a simple food diary for the first fortnight helps identify personal triggers, some people find dairy or high-fibre foods are the culprit; others notice it is specific meal sizes rather than specific foods.
Hydration deserves emphasis here. Reduced appetite on tirzepatide means some people are eating and drinking less overall, so diarrhoea can tip the balance towards dehydration faster than it ordinarily would. Plain water, diluted squash, and oral rehydration sachets are all reasonable choices if diarrhoea is frequent.
Most diarrhoea on Mounjaro is self-limiting and manageable at home. There are situations, though, where prompt medical attention matters. Seek help the same day if you notice blood or mucus in your stool, if diarrhoea has lasted more than four or five days without any sign of improvement, or if you are unable to keep fluids down alongside it. Signs of dehydration (dizziness, a dry mouth, very dark urine, or feeling faint when you stand) also warrant a call to your GP or 111.
Separately, tirzepatide carries a known but infrequent risk of acute pancreatitis. The MHRA issued a Drug Safety Update on this on 29 January 2026, emphasising that severe stomach pain reaching the back, especially when combined with vomiting, needs urgent assessment. Diarrhoea alone is not a sign of pancreatitis, but if it occurs alongside that kind of pain, do not wait and see. You can report any suspected side effect, including persistent diarrhoea, directly through the MHRA Yellow Card scheme.
Your prescriber is always the right person to guide any adjustment to your treatment. At nume, a named clinician reviewed your consultation before your prescription was issued, that same prescribing team is reachable through our aftercare support seven days a week if you need to raise a concern about side effects. Never adjust your dose or skip an injection without clinical guidance; dose timing and titration questions belong with your prescriber and the Patient Information Leaflet, not an internet search.
Rarely, on its own. The clinical evidence behind tirzepatide (including the SURMOUNT-1 trial published in the New England Journal of Medicine) shows that gastrointestinal side effects were the most common reason participants reduced their dose or paused treatment, but most managed to continue with adjustments. A prescriber can advise whether a temporary pause, a slower titration, or dietary changes are the right call for your specific circumstances.
If you are still weighing up treatment, the Mounjaro overview page gives a balanced picture of how the medicine works and what the trial results showed. For a broader look at what different weight-loss treatments involve, the weight-loss treatment overview is a straightforward starting point. And if you are curious about cost before committing to a consultation, there is an honest breakdown on the Mounjaro cost context page, spoiler: the lowest price is not always the right measure for a prescription medicine.
The short answer is this: diarrhoea on Mounjaro is unpleasant, usually temporary, and almost always manageable. It is a reason to adjust your approach, not to assume the treatment is not for you. If it is persistent, severe or accompanied by anything alarming, get medical input promptly. That is what the clinical team is there for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.